POMT2 gene
The POMT2 gene provides instructions for an enzyme complex that modifies alpha-dystroglycan, a protein critical for muscle stability and brain development.
Normal Function
The POMT2 gene encodes a component of the protein O-mannosyltransferase (POMT) enzyme complex. This complex adds a sugar molecule (mannose) to alpha-dystroglycan, a process known as glycosylation. Glycosylated alpha-dystroglycan is essential for:
- Muscle stability: Anchoring the cytoskeleton to the extracellular matrix to protect muscle fibers during contraction.
- Brain development: Directing the migration of neurons during early development.
Health Conditions Related to Genetic Changes
Walker-Warburg syndrome
Mutations in POMT2 can lead to a nonfunctional POMT enzyme complex, preventing the glycosylation of alpha-dystroglycan. This results in:
- Severe muscle weakness
- Cobblestone lissencephaly: A brain abnormality where neurons migrate past their intended destination, causing the brain surface to appear bumpy and irregular.
- Eye abnormalities.
Other disorders
Less severe mutations in POMT2 can lead to other forms of muscular dystrophy, such as muscle-eye-brain disease and POMT2-related congenital muscular dystrophy. In these cases, the POMT enzyme complex retains partial function. The severity of the condition generally correlates with the level of alpha-dystroglycan glycosylation; lower levels of glycosylation result in more severe symptoms.
Other Names for This Gene
- dolichyl-phosphate-mannose--protein mannosyltransferase 2
- LGMD2N
- MDDGA2
- MDDGB2
- MDDGC2
- POMT2_HUMAN
- protein O-mannosyl-transferase 2
- protein-O-mannosyltransferase 2
